Someone just brought this company to my attention yesterday and looking to casually do some DD. While I listen to the recent interviews/ presos, appreciate if you can point me in the direction of any other useful info on these threads.
The science itself seems good and addressing some unmet need. Mgmt look good on paper. Looking at 4 phase 2 trials and the cash, both on hand and what’s projected to be received, still leaves me feeling they may need a CR before mid-2025 unless they can sign partnerships who may front up capital. JIMHO. Keen to hear some thoughts.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.003(4.76%) |
Mkt cap ! $97.55M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.6¢ | 6.0¢ | $154.2K | 2.423M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 273330 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| SNT (ASX) Chart |